Dr. Michael Fletcher

Senior Editor, Nature Genetics

Michael Fletcher (ORCID) studied for his Ph.D. at Cancer Research UK’s Cambridge Institute at the University of Cambridge in the laboratory of Bruce Ponder. His project used systems biology approaches to identify the functional mechanism by which FGFR2, a breast cancer risk locus identified using GWAS, exerts its effect. He then moved to Germany and was a postdoctoral fellow in the Molecular Genetics department of Peter Lichter at the German Cancer Research Center in Heidelberg, where he performed bioinformatic analysis to help characterize the epigenomic and master regulator landscapes of adult glioblastoma. He joined the journal in 2020 and is based in Berlin, Germany.